A team of researchers from Luxembourg has found a simple panel of eight genetic biomarkers may be able to identify which patients are at a high risk for developing CRC following a screening colonoscopy, according to a Medscape report.
The researchers presented their data at the 17th World Congress on Gastrointestinal Cancer held July 1 to July 4 in Barcelona, Spain.
The test uses standard blood samples and could be done at any time. The researchers found that a panel with just three of the eight studied biomarkers was almost as accurate. The test could serve as a low-cost option for determining which patients are candidates for repeat colonoscopy, according to the report.
More articles on gastroenterology:
4 GI physicians in the news – July 6, 2015
FDA clears 3 GI/endoscopy devices in June
11 GI/endoscopy center openings, plans & acquisitions in 2015
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
